Fitzgibbon GM, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616–26.
Article CAS PubMed Google Scholar
Goel SA, et al. Mechanisms of post-intervention arterial remodelling. Cardiovasc Res. 2012;96(3):363–71.
Article CAS PubMed PubMed Central Google Scholar
Goldman S, et al. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial. JAMA. 2011;305(2):167–74.
Article CAS PubMed Google Scholar
Cai C, et al. Adventitial delivery of nanoparticles encapsulated with 1α, 25-dihydroxyvitamin D(3) attenuates restenosis in a murine angioplasty model. Sci Rep. 2021;11(1):4772.
Article CAS PubMed PubMed Central Google Scholar
Jeong Y, Yao Y, Yim E. Current understanding of intimal hyperplasia and effect of compliance in synthetic small diameter vascular grafts. Biomater Sci. 2020;8(16):4383–95.
Article CAS PubMed PubMed Central Google Scholar
Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49(2):208–15.
Regar E, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation. 2002;106(15):1949–56.
Article CAS PubMed Google Scholar
Kayssi A, et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries. Cochrane Database Syst Rev. 2019;1:CD012510.
Katsanos K, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(24):e011245.
Dan K, et al. Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality. Am Heart J. 2020;222:112–20.
Article CAS PubMed Google Scholar
Gonschior P, et al. Local drug administration systems, preclinical and clinical use: perspectives and limitations. Z Kardiol. 1996;85(3):155–65.
Kuwahara G, et al. CD44 Promotes inflammation and extracellular matrix production during arteriovenous fistula maturation. Arterioscler Thromb Vasc Biol. 2017;37(6):1147–56.
Article CAS PubMed PubMed Central Google Scholar
Cai C, et al. Therapeutic effect of adipose derived mesenchymal stem cell transplantation in reducing restenosis in a murine angioplasty model. J Am Soc Nephrol. 2020;31(8):1781–95.
Article CAS PubMed PubMed Central Google Scholar
Chaudhary MA, et al. Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery. J Control Release. 2016;233:174–80.
Article CAS PubMed PubMed Central Google Scholar
Razavi MK, et al. Adventitial drug delivery of dexamethasone to improve primary patency in the treatment of superficial femoral and popliteal artery disease: 12-month results from the DANCE clinical trial. JACC Cardiovasc Interv. 2018;11(10):921–31.
Gasper WJ, et al. Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation. Circ Cardiovasc Interv. 2013;6(6):701–9.
Article CAS PubMed PubMed Central Google Scholar
Bai H, et al. A novel intramural TGF beta 1 hydrogel delivery method to decrease murine abdominal aortic aneurysm and rat aortic pseudoaneurysm formation and progression. Biomed Pharmacother. 2021;137:111296.
Sun P, et al. Immune checkpoint programmed death-1 mediates abdominal aortic aneurysm and pseudoaneurysm progression. Biomed Pharmacother 2021;142:111955.
Bai H, et al. Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasia. Sci Rep. 2017;7:40142.
Article CAS PubMed PubMed Central Google Scholar
Xie B, et al. A novel plant leaf patch absorbed with il-33 antibody decreases venous neointimal hyperplasia. Front Bioeng Biotechnol. 2021;9: 742285.
Bai H, et al. Application of the tissue-engineered plant scaffold as a vascular patch. ACS Omega. 2021.
McMonagle MP. The quest for effective pharmacological suppression of neointimal hyperplasia. Curr Probl Surg. 2020;57(8):100807.
Owens CD, et al. Vein graft failure. J Vasc Surg. 2015;61(1):203–16.
Desai M, et al. Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath. Vasc Med. 2010;15(4):287–97.
Tesfamariam B. Bioresorbable scaffold-based controlled drug delivery for restenosis. J Cardiovasc Transl Res. 2019;12(3):193–203.
Sethi SS, Lee MS. Drug-coated balloons for infrainguinal peripheral artery disease. J Invasive Cardiol. 2016;28(7):281–6.
Bague N, et al. The role for DCBs in the treatment of ISR. J Cardiovasc Surg (Torino). 2016;57(4):578–85.
Seedial SM, et al. Local drug delivery to prevent restenosis. J Vasc Surg. 2013;57(5):1403–14.
Article PubMed PubMed Central Google Scholar
Tesfamariam BJVp. Periadventitial local drug delivery to target restenosis. 2017.
Buglak NE, Bahnson ESM. A rat carotid artery pressure-controlled segmental balloon injury with periadventitial therapeutic application. J Vis Exp. 2020(161).
Helkin A, et al. Intraluminal delivery of simvastatin attenuates intimal hyperplasia after arterial injury. Vasc Endovascular Surg. 2019;53(5):379–86.
Wu B, et al. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. J Vasc Surg. 2018;68(6S):188S-200S e4.
Varga N, et al. The effect of synthesis conditions and tunable hydrophilicity on the drug encapsulation capability of PLA and PLGA nanoparticles. Colloids Surf B Biointerfaces. 2019;176:212–8.
Article CAS PubMed Google Scholar
Jiang Y, et al. Nanoparticle-hydrogel superstructures for biomedical applications. J Control Release. 2020;324:505–21.
Article CAS PubMed PubMed Central Google Scholar
Wei S, et al. Hydrogel-coated needles prevent puncture site bleeding. Acta Biomater. 2021;128:305–13.
Article CAS PubMed Google Scholar
Shi X, et al. Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis. PLoS One. 2014;9(2):e89227.
Wei S, et al. A three-layered hydrogel patch with hierarchy releasing of PLGA nanoparticle drugs decrease neointimal hyperplasia. Smart Mater Med. 2022;3:139–47.
Bai H, et al. Transforming growth factor-β1 inhibits pseudoaneurysm formation after aortic patch angioplasty. Arterioscler Thromb Vasc Biol. 2018;38(1):195–205.
Article CAS PubMed Google Scholar
Ikeno F, et al. Novel percutaneous adventitial drug delivery system for regional vascular treatment. Catheter Cardiovasc Interv. 2004;63(2):222–30.
Jank M, et al. Platelet bone morphogenetic protein-4 mediates vascular inflammation and neointima formation after arterial injury. Cells. 2021;10(8).
Bai H, et al. Biomimetic elastin fiber patch in rat aorta angioplasty. ACS Omega. 2021;6(40):26715–21.
Article CAS PubMed PubMed Central Google Scholar
Bai H, et al. Artery to vein configuration of arteriovenous fistula improves hemodynamics to increase maturation and patency. Sci Transl Med. 2020;12(557).
McCall RL, Sirianni RW. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp. 2013;82:51015.
Wang Z, et al. Preparing a novel magnesium-doped hyaluronan/polyethyleneimine nanoparticle to improve endothelial functionalisation. IET Nanobiotechnol. 2020;14(2):142–7.
Article PubMed PubMed Central Google Scholar
Zhang K, et al. Potential application of an injectable hydrogel scaffold loaded with mesenchymal stem cells for treating traumatic brain injury. J Mater Chem B. 2018;6(19):2982–92.
留言 (0)